[topsearch__bar__shortcode]

December 23, 2021

Why is Ortho Clinical Diagnostics Holdings plc (OCDX) stock rising today?

Shares of the Ortho Clinical Diagnostics Holdings plc (OCDX) stock were rising in the current market today on December 23, 2021. OCDX stock price saw a push of 7.12% to reach $21.22 a share at the time of this writing. The stock was also green in the previous trade and went up by 1.54% at […]

Why is Ortho Clinical Diagnostics Holdings plc (OCDX) stock rising today? Read More »

Inspira Technologies Oxy B.H.N. Ltd. (IINN) Stock Declining Today. Here’s What you Should Know

Inspira Technologies Oxy B.H.N. Ltd. (IINN) is a leader in the development of medical tools and devices mainly focusing on respiratory care. One of the lead product devices of the company is augmented respiratory technology (ART), or artificial lung for patients with debilitating respiratory systems. A hemo-protective flow approach is utilized in this device which

Inspira Technologies Oxy B.H.N. Ltd. (IINN) Stock Declining Today. Here’s What you Should Know Read More »

Here’s the Reason of Meten Holding Group, Inc. (METX) Stock Climbing in Pre Market

Meten Holding Group, Inc. (METX) is one of the leading English language training service providers in China. The company provides training and skills in the English language to students and professionals. The company is also involved in the businesses outside China related to blockchain and cryptocurrency mining, mining farm construction, and also mining pool and

Here’s the Reason of Meten Holding Group, Inc. (METX) Stock Climbing in Pre Market Read More »

Here’s why the Mereo BioPharma Group PLC (MREO) Stock Gained Momentum in the Pre Market

Mereo BioPharma Group PLC (MREO) is leading oncology and rare diseases-related biopharmaceutical company. The main product candidate of the company is etigilimab (OMP-313M32) for the prevention of tumors. Another lead product of the company used for the prevention of late-line ovarian cancer is navicixizumab. The two rare diseases candidates of MREO include alvelestat (prevent Alpha-1

Here’s why the Mereo BioPharma Group PLC (MREO) Stock Gained Momentum in the Pre Market Read More »

Genocea Biosciences, Inc. (GNCA) stock rallied in the premarket: Here’s Why

Shares of the Genocea Biosciences, Inc. (GNCA) stock rallied in the premarket today on December 23, 2021. GNCA stock price saw a push of 18.27% to reach $1.23 a share at the time of this writing. The stock was also green in the previous trade and went up by 7.23% at closing. Let’s dig in

Genocea Biosciences, Inc. (GNCA) stock rallied in the premarket: Here’s Why Read More »

Biocardia Inc. (BCDA) Stock Took a Leap in the Pre-Market Despite any Visible Reason

Biocardia Inc. (BCDA) is an innovative regenerative therapeutics company that develops medication for different cardiovascular indications. One of the lead product candidates of the company is CardiAMP used for the treatment of myocardial infarction and chronic myocardial ischemia. Another product candidate in Phase 1/2 trials is NK1R+ allogeneic bone marrow-derived mesenchymal stem cell therapy for

Biocardia Inc. (BCDA) Stock Took a Leap in the Pre-Market Despite any Visible Reason Read More »

SeaChange International, Inc. (SEAC) Stock on a Rally, Here’s the Reason

SeaChange International, Inc. (SEAC), a company that provides multiscreen, advertising, and premium over the top (OTT) video products and services, has increased by 4.59% in aftermarket trading session. As a result, SEAC stock is trading at $2.05 at the time of the writing. On Wednesday, SEAC closed the day at $1.96 after surging 9.50% during

SeaChange International, Inc. (SEAC) Stock on a Rally, Here’s the Reason Read More »